Navigation Links
Alfacell Reports Fiscal Fourth Quarter and Full Year 2008 Financial Results
Date:10/14/2008

ing diseases. In addition to a recently completed Phase IIIb study in malignant mesothelioma, Alfacell is currently planning for Phase II clinical trials in other oncology indications. For more information, visit http://www.alfacell.com.

Safe Harbor

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, uncertainty whether the clinical trial results will allow the company to complete submission of a New Drug Application and if a New Drug Application submission is completed, uncertainty whether FDA will file or approve such application, uncertainties involved in transitioning from concept to product, uncertainties involving the ability of the company to finance research and development activities, potential challenges to or violations of patents, uncertainties regarding the outcome of clinical trials or differences of opinion in interpreting the results of clinical trials, the company's ability to secure necessary approvals from regulatory agencies, dependence upon third-party vendors, and other risks discussed in the company's periodic filings with the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this release.

ALFACELL CORPORATION

Condensed Statements of Operations

Three-Months Ended Fiscal Year Ended

July 31 July 31

2008 2007 2008
'/>"/>

SOURCE Alfacell Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Paper in Cell Cycle Reports Alfacells ONCONASE(R) Targets siRNA
2. Alfacell Hires Advisors to Advance Strategic Alternatives
3. Alfacell Receives NASDAQ Delisting Letter
4. Alfacell Receives NASDAQ Non-Compliance Notification
5. Alfacell Reports Financial Results for Third Quarter of Fiscal 2008
6. Alfacell Announces Retirement of Chief Executive Officer
7. Alfacell Reports Financial Results for Second Quarter of Fiscal 2008
8. Alfacell to Host Fiscal Second Quarter 2008 Financial Results Conference Call and Webcast
9. Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
10. Alfacell to Host Webinar on RNA Interference-Like Mechanics of RNase Therapeutics on Nov. 29
11. Alfacell to Host Fiscal Fourth Quarter and Year-End 2007 Financial Results Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... NY (PRWEB) January 14, 2014 EquitiesIQ, ... Alliqua, Inc. (OTCQB: ALQA). Alliqua is an emerging biomedical ... serve the wound care market. , Free report download: ... restructured with a seasoned management team and Board, which ...
(Date:1/14/2014)... Md. , Jan. 14, 2014  Organovo announced today ... the National Institutes of Health (NIH) to help scientists ... treatments to patients on a faster timeline. Organovo is ... (NCATS) and the National Eye Institute (NEI) to develop ...
(Date:1/14/2014)... 14, 2014 In recent years, growing ... methods in product development and promotion has led to ... mistrust, fueled by concerns about the insidious impact of ... of spectacular fines to the world’s biggest pharmas for ...
(Date:1/14/2014)... Global Record Systems, LLC, (GRS), a ... for patients, physicians, the biopharmaceutical industry, regulators, payers, ... signing of a three-year Research Collaboration Agreement (RCA) ... This initiative is designed to generate disruptive ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... N.C., March 25 TeleHealth Services, the ... solutions to hospitals, today announced that it has been ... system,s strategy to enhance the hospital stay for patients ... improving the hospital experience by being progressive and consumer ...
... /PRNewswire-FirstCall/ - Spectral Diagnostics Inc. (TSX:SDI), a company ... announced that the 29th International Symposium on Intensive ... March 24-27, 2009 will feature a key scientific ... include presentations from six thought leaders in the ...
... Senator Katherine Laforge. With stakes higher than they,ve ever been before, Batman ... America to OPEC forever. The message that Batman and Senator Katherine Laforge ... from OPEC and put an end to financing our own destruction. , ... (Vocus) March ...
Cached Biology Technology:TeleHealth Services and Lakeland HealthCare Connect to Create Outstanding Patient Experience 2TeleHealth Services and Lakeland HealthCare Connect to Create Outstanding Patient Experience 3Spectral announces presentations at the 29TH International Symposium on Intensive Care and Emergency Medicine focusing on the role of endotoxin 2Batman Teams with Senator Katherine Laforge to Help Free America from OPEC 2Batman Teams with Senator Katherine Laforge to Help Free America from OPEC 3Batman Teams with Senator Katherine Laforge to Help Free America from OPEC 4Batman Teams with Senator Katherine Laforge to Help Free America from OPEC 5
(Date:4/23/2014)... a signing ceremony in Buenos Aires yesterday, Argentina ... an associate member state. The move strengthens the ... science communities. It grants Argentinian scientists access to ... beneficial collaborations. , "Ever since its inception, fostering ... have been at the core of EMBL,s mission," ...
(Date:4/23/2014)... Sophie Martin of the University of Lausanne, Switzerland, as ... award acknowledges her work to understand the molecular events ... , Martin has been working for the past 15 ... in which the spatial organization of cells contributes to ... years, she has been using fission yeast, which grow ...
(Date:4/23/2014)... a University of Exeter researcher has shed light on ... thriving in Australia,s remote outback have become reviled as ... Crowley, of the Environment and Sustainability Institute at the ... the camel in Australia, from their historic role helping ... status as unwelcome "invader." , The deserts of the ...
Breaking Biology News(10 mins):EMBO Gold Medal 2014 awarded to Sophie Martin 2How Australia got the hump with 1 million feral camels 2How Australia got the hump with 1 million feral camels 3
... Scientist Jiř Friml from VIB and Ghent University, ... the Krber European Science Award, worth 750 000 euro. ... pursuing particularly innovative research projects. Friml gets the prize ... plants. "Friml,s work on the genetic, molecular and ...
... consequences of emerging infectious diseases on crops in ... are often underestimated, according to a new study ... Institute of the Science of Food Production in ... international communities to establish better mechanisms for monitoring ...
... COLUMBIA, Mo. A University of Missouri doctoral student has ... to take some of the guesswork out of wetland identification. ... of Engineers, manual on wetlands identification is 143 pages long. ... wetlands aren,t always wet. One important tool is looking at ...
Cached Biology News:VIB-UGent scientist Jiri Friml receives Koerber European Science Award 2010 2Plant disease -- more than a crop killer 2Taking the guesswork out of soil classification 2Taking the guesswork out of soil classification 3